$AEYE
AUDIOEYE INC Stock $aeye

$aeye Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000114420416101658 Filed on May 13, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$124.7K	$101.0K
YoY Change	23.42%	-90.22%
Cost Of Revenue	$294.8K	$462.1K
YoY Change	-36.21%	1022.96%
Gross Profit	-$170.1K	-$361.1K
YoY Change	-52.89%	-136.41%
Gross Profit Margin	-136.41%	-357.38%
Selling, General & Admin	$594.4K	$2.388M
YoY Change	-75.11%	10.38%
% of Gross Profit
Research & Development	$85.62K	$142.3K
YoY Change	-39.83%	8.92%
% of Gross Profit
Depreciation & Amortization	$0.00	$130.0K
YoY Change	-100.0%	30.0%
% of Gross Profit
Operating Expenses	$818.5K	$2.664M
YoY Change	-69.27%	11.29%
Operating Profit	-$988.7K	-$3.025M
YoY Change	-67.32%	115.79%
Interest Expense	-$110.2K	$3.107K
YoY Change	-3645.7%	-55.51%
% of Operating Profit
Other Income/Expense, Net	-$3.522M	$3.107K
YoY Change	-113464.15%	-144.49%
Pretax Income	-$4.510M	-$3.020M
YoY Change	49.34%	39.17%
Income Tax
% Of Pretax Income
Net Earnings	-$4.511M	-$3.022M
YoY Change	49.28%	114.5%
Net Earnings / Revenue	-3617.32%	-2990.76%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.379M	-$958.7K
COMMON SHARES
Basic Shares Outstanding	81.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.130M	$820.0K
YoY Change	37.8%	67.35%
Cash & Equivalents	$1.080M	$760.3K
Short-Term Investments	$50.00K	$60.00K
Other Short-Term Assets	$40.00K	$140.0K
YoY Change	-71.43%	180.0%
Inventory
Prepaid Expenses
Receivables	$19.28K	$20.00K
Other Receivables	$0.00	$10.00K
Total Short-Term Assets	$1.190M	$1.000M
YoY Change	19.0%	-47.94%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00
YoY Change		-100.0%
Goodwill	$700.5K
YoY Change
Intangibles	$2.738M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.444M	$3.690M
YoY Change	-6.68%	-18.62%
TOTAL ASSETS
Total Short-Term Assets	$1.190M	$1.000M
Total Long-Term Assets	$3.444M	$3.690M
Total Assets	$4.634M	$4.690M
YoY Change	-1.2%	-27.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$270.0K	$510.0K
YoY Change	-47.06%	-60.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$20.00K	$20.00K
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$4.434M	$560.0K
YoY Change	691.7%	-60.6%
LONG-TERM LIABILITIES
Long-Term Debt	$1.960M	$40.00K
YoY Change	4800.0%	-42.86%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.960M	$40.00K
YoY Change	4800.0%	-42.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.434M	$560.0K
Total Long-Term Liabilities	$1.960M	$40.00K
Total Liabilities	$6.397M	$610.0K
YoY Change	948.71%	-59.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.75M
YoY Change
Common Stock	$817.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$623.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.763M	$4.090M
YoY Change
Total Liabilities & Shareholders Equity	$4.634M	$4.690M
YoY Change	-1.2%	-27.35%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$4.511M	-$3.022M
YoY Change	49.28%	114.5%
Depreciation, Depletion And Amortization	$0.00	$130.0K
YoY Change	-100.0%	30.0%
Cash From Operating Activities	-$560.0K	-$2.420M
YoY Change	-76.86%	89.75%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$30.00K
YoY Change	-100.0%	-72.73%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$40.00K	-$30.00K
YoY Change	33.33%	-73.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$325.0K
YoY Change	-100.0%	79.03%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	1.540M
YoY Change	-100.65%	4358.99%
NET CHANGE
Cash From Operating Activities	-560.0K	-2.420M
Cash From Investing Activities	-40.00K	-30.00K
Cash From Financing Activities	-10.00K	1.540M
Net Change In Cash	-610.0K	-910.0K
YoY Change	-32.97%	-32.81%
FREE CASH FLOW
Cash From Operating Activities	-$560.0K	-$2.420M
Capital Expenditures	$0.00	-$30.00K
Free Cash Flow	-$560.0K	-$2.390M
YoY Change	-76.57%	105.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4433505	USD
CY2015Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	153474	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2840856	USD
CY2016Q1	us-gaap	Goodwill Goodwill	700528	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	213620	USD
CY2016Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	135710	USD
CY2016Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	24000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	700528	USD
CY2016Q1	us-gaap	Assets Assets	4633673	USD
CY2015Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	24000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	891245	USD
CY2016Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	272079	USD
CY2016Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2738385	USD
CY2015Q4	us-gaap	Assets Assets	5346370	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22741	USD
CY2016Q1	us-gaap	Long Term Debt LongTermDebt	1963640	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	1923499	USD
CY2016Q1	us-gaap	Liabilities Liabilities	6397145	USD
CY2015Q4	us-gaap	Liabilities Liabilities	2814744	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	2	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	2	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	817	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	817	USD
CY2016Q1	us-gaap	Treasury Stock Value TreasuryStockValue	623000	USD
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	623000	USD
CY2016Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3600	USD
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3600	USD
CY2016Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	50000	USD
CY2015Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	50000	USD
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	150296	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	60790	USD
CY2016Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3851420	USD
CY2015Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	439361	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	294808	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	462131	USD
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27609016	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27393238	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28750307	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24239431	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	-1763472	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	2531626	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4633673	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5346370	USD
CY2016Q1	us-gaap	Cash Cash	1080490	USD
CY2015Q4	us-gaap	Cash Cash	1687257	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19282	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3021806	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-29650	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	325000	USD
CY2016Q1	aeye	Increase Decrease In Stock Subscription Receivable IncreaseDecreaseInStockSubscriptionReceivable	0	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	-170106	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	-361093	USD
CY2016Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	123366	USD
CY2015Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	366368	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	85617	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	142282	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	471025	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2021226	USD
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	138538	USD
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	133944	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	818546	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	2663820	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-988652	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3024913	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	124702	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	101038	USD
CY2016Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-3412059	USD
CY2015Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2016Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-110165	USD
CY2015Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3107	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3522224	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3107	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-4510876	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-3021806	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	81717154	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78736420	shares
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	21875	USD
CY2015Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4532751	USD
CY2016Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	138538	USD
CY2015Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	133944	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	215778	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	559793	USD
CY2015Q1	aeye	Common Stock Issuance Costs CommonStockIssuanceCosts	314663	USD
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	46141	USD
CY2015Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3459	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-237758	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-274164	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-564700	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2418916	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-36067	USD
CY2015Q1	aeye	Increase Decrease In Stock Subscription Receivable IncreaseDecreaseInStockSubscriptionReceivable	-1175000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-6000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1535942	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-606767	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1687257	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-912624	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1672901	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1080490	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	760277	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	43942	USD
CY2015Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	48713	USD
CY2016Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	0	USD
CY2016Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	36067	USD
CY2015Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	29650	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	307	USD
CY2016Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2015Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1574318	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1435780	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2840856	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2738385	USD
CY2016Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1945840	USD
CY2015Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1899699	USD
CY2015	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2500000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	627293	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	833334	shares
CY2016Q1	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod	0	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.06
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81717154	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81717154	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81717154	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81717154	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-6000	USD
CY2015Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-8000	USD
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="BACKGROUND: transparent">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4	aeye	Common Stock Issuance Price Per Share CommonStockIssuancePricePerShare	0.10
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
CY2016Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2016Q1	us-gaap	Share Price SharePrice	0.161
CY2016Q1	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0121	pure
CY2016Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3851420	USD
CY2016Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	3412059	USD
CY2015Q4	aeye	Notes And Warrants Exercisable Description NotesAndWarrantsExercisableDescription	Notes representing up to $2,500,000 in aggregate principal, and Warrants exercisable for up to 25,000,000 shares of Common Stock in the aggregate, may be issued and sold at one or more closings during the 30-day period immediately following the Initial Closing Date.
CY2015Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2500000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	Vesting shall only occur if the closing share price of the Company’s common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition).
CY2016Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1500	USD
CY2016Q1	aeye	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P3Y25D
CY2015	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	42526609	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	43359943	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.22
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.21
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y1M24D
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y10M13D
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1167	USD
CY2016Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1666625	USD
CY2015Q4	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	41047920	shares
CY2016Q1	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	43141193	shares
CY2015Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2000000	USD
CY2016Q1	aeye	Working Capital Amount WorkingCapitalAmount	3238745	USD
CY2016Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	554160	USD
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	600301	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	138538	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	133944	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-17764	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-91408	USD
CY2016Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	-89506	USD
CY2015Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	228983	USD
CY2016Q1	aeye	Common Stock Issuance Costs CommonStockIssuanceCosts	0	USD
CY2016Q1	aeye	Working Capital WorkingCapital	612675	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3600	USD
CY2016Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Reclassification</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Certain prior year amounts have been reclassified to conform to the current year presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4	aeye	Class Of Warrant Or Right Exercisable Number ClassOfWarrantOrRightExercisableNumber	25000000	shares
CY2015Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2500000	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10

Files In Submission

Name	View Source	Status
0001144204-16-101658-index-headers.html	Edgar Link	pending
0001144204-16-101658-index.html	Edgar Link	pending
0001144204-16-101658.txt	Edgar Link	pending
0001144204-16-101658-xbrl.zip	Edgar Link	pending
aeye-20160331.xml	Edgar Link	completed
aeye-20160331.xsd	Edgar Link	pending
aeye-20160331_cal.xml	Edgar Link	unprocessable
aeye-20160331_def.xml	Edgar Link	unprocessable
aeye-20160331_lab.xml	Edgar Link	unprocessable
aeye-20160331_pre.xml	Edgar Link	unprocessable
audioeyelogo.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v438533_10q.htm	Edgar Link	pending
v438533_ex31-1.htm	Edgar Link	pending
v438533_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AEYE
AUDIOEYE INC Stock $aeye

2016 Q1 Form 10-Q Financial Statement

#000114420416101658 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AEYE AUDIOEYE INC Stock $aeye

2016 Q1 Form 10-Q Financial Statement

#000114420416101658 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AEYE
AUDIOEYE INC Stock $aeye